We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Patients With Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00437268
Recruitment Status : Completed
First Posted : February 19, 2007
Last Update Posted : April 20, 2010
Information provided by:
Eli Lilly and Company

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2009
  Study Completion Date : May 2009
  Certification or Request for Extension to Delay Results Submission: April 16, 2010